" class="no-js "lang="en-US"> James Osborne Archives - Pharmtech Focus
Wednesday, February 01, 2023

Breaking News

Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC) AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics CARsgen Announces Collaboration Agreement with Roche to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer ProtaGene Appoints New Scientific and Commercial Leadership to Support Evolving Needs of Biologic and Cell & Gene Therapy Innovators MyndVR Partners with AgeWell New York for First Health Care Coverage Plan

Sort by:

Date

Top Post

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition | PTF

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

Read more

Appointments

 Amphista Therapeutics Expands Research Team by Appointing Martin O'Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry | Pharmtech Focus

Amphista Therapeutics Expands Research Team by Appointing Martin O'Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry

Amphista Therapeutics, a Targeted Protein Degradation (TPD) biopharmaceutical company creating first-in-class cancer therapeutics that harness […]

  1. Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers

    Mergers & Aquisitions

     Read more
  2. Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)

    Diseases

     Read more
  3. AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors

    Appointments

     Read more
  4. Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia

    News

     Read more
  5. Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer

    Appointments

     Read more